A detailed history of Carr Financial Group Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Carr Financial Group Corp holds 4,282 shares of BMY stock, worth $240,734. This represents 0.06% of its overall portfolio holdings.

Number of Shares
4,282
Holding current value
$240,734
% of portfolio
0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$39.66 - $51.75 $169,824 - $221,593
4,282 New
4,282 $222 Million
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $193,592 - $229,241
2,827 New
2,827 $203 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Carr Financial Group Corp Portfolio

Follow Carr Financial Group Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carr Financial Group Corp, based on Form 13F filings with the SEC.

News

Stay updated on Carr Financial Group Corp with notifications on news.